Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|October 8, 2017
Establishment of the CRISPR/Cas9 System for Targeted Gene Disruption and Gene TaggingEric Ehrke-Schulz, Maren Schiwon, Claudia Hagedorn, et al.
Human Gene Therapy|August 1, 2026
Helper-Dependent Adenoviral Vectors: Recent Advances and Emerging ApplicationsMontaha Alshawabkeh, Eric Ehrke-Schulz, Wenli Zhang, et al.
Human Gene Therapy|September 1, 2017
Recent Advances in Preclinical Developments Using Adenovirus Hybrid VectorsEric Ehrke-Schulz, Wenli Zhang, Jian Gao, et al.
Cancers|July 26, 2020
Adenoviral Vectors Armed with PAPILLOMAVIRUs Oncogene Specific CRISPR/Cas9 Kill Human-Papillomavirus-Induced Cervical Cancer CellsEric Ehrke-Schulz, Sonja Heinemann, Lukas Schulte, et al.
Molecular Therapy. Nucleic Acids|July 20, 2016
A High-Capacity Adenoviral Hybrid Vector System Utilizing the Hyperactive Sleeping Beauty Transposase SB100X for Enhanced IntegrationPhilip Boehme, Wenli Zhang, Manish Solanki, et al.
Molecular Therapy. Nucleic Acids|January 29, 2019
Viral Vector-Based Delivery of CRISPR/Cas9 and Donor DNA for Homology-Directed Repair in an In Vitro Model for Canine Hemophilia BJian Gao, Thorsten Bergmann, Wenli Zhang, et al.
Viruses|March 28, 2024
Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical ApplicationsLuca Scarsella, Eric Ehrke-Schulz, Michael Paulussen, et al.
Molecular Therapy. Methods & Clinical Development|July 16, 2016
Quantification of designer nuclease induced mutation rates: a direct comparison of different methodsEric Ehrke-Schulz, Thorsten Bergmann, Maren Schiwon, et al.
Scientific Reports|December 8, 2017
CRISPR/Cas9 delivery with one single adenoviral vector devoid of all viral genesEric Ehrke-Schulz, Maren Schiwon, Theo Leitner, et al.
Molecular Therapy. Nucleic Acids|September 10, 2018
One-Vector System for Multiplexed CRISPR/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral VectorsMaren Schiwon, Eric Ehrke-Schulz, Andreas Oswald, et al.
Pageof 3